⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4259672 | 1.00 | — | — | |
| SCHEMBL594188 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL1758764 | 0.91 | SLC7A5 (0.46) | — | |
| SCHEMBL28890361 | 0.85 | USP2 (0.57) | — | |
| SCHEMBL11855669 | 0.83 | USP2 (0.59) | — | |
| SCHEMBL10971625 | 0.83 | USP2 (0.59) | — | |
| SCHEMBL4755452 | 0.80 | SLC7A5 (0.50) | — | |
| SCHEMBL1236513 | 0.80 | SLC7A5 (0.50) | — | |
| Isoleucine SCHEMBL22807324 | 0.80 | SLC7A5 (0.50) | — | |
| SCHEMBL1236514 | 0.80 | SLC7A5 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250276073-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1) | BICYCLETX LIMITED (GB) | 2025-09-04 | — | — | US | claimed |
| EP-4519299-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TFR1) | BicycleTx Limited (GB) | 2025-03-12 | — | — | EP | claimed |
| WO-2023214162-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1) | BICYCLETX LIMITED (GB) | 2023-11-09 | — | — | WO | claimed |
| US-20220024982-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP | BICYCLETX LIMITED (GB) | 2022-01-27 | — | — | US | claimed |
| EP-3894010-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP | BicycleTX Limited (GB) | 2021-10-20 | — | — | EP | claimed |
| CN-113507962-A | MT1-MMP specific bicyclic peptide ligands | 拜斯科技术开发有限公司 | 2021-10-15 | — | — | CN | claimed |
| WO-2020120984-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP | BICYCLETX LIMITED (GB) | 2020-06-18 | — | — | WO | claimed |
| WO-2020081958-A2 | COMPOSITIONS AND METHODS FOR IDENTIFYING MUTATIONS OF GENES OF MULTI-GENE SYSTEMS HAVING IMPROVED FUNCTION | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2020-04-23 | — | — | WO | claimed |
| US-9101662-B2 | Compositions with modulating agents | FOAMIX PHARMACEUTICALS LTD. (IL) | 2015-08-11 | — | — | US | claimed |
| US-8795693-B2 | Compositions with modulating agents | FOAMIX LTD. (IL) | 2014-08-05 | — | — | US | claimed |
| EP-2315604-A2 | DICARBA-ANALGUES OF OCTREOTIDE | Advanced Accelerator Applications S.A. (FR) | 2011-05-04 | — | — | EP | claimed |
| WO-2010004512-A2 | DICABBA-ANALOGUES OF OCTREOTIDE | ADVANCED ACCELERATOR APPLICATIONS S.A. (FR) | 2010-01-14 | — | — | WO | claimed |
| EP-2097065-A2 | FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS | Foamix Ltd. (IL) | 2009-09-09 | — | — | EP | claimed |
| WO-2008152444-A2 | FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS | FOAMIX LTD. (US) | 2008-12-18 | — | — | WO | claimed |
| US-20080206159-A1 | Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions | FOAMIX LTD. (IL) | 2008-08-28 | — | — | US | claimed |
| WO-2004021981-A2 | METHODS FOR THE PREPARATION OF β-AMINO ACIDS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2004-03-18 | — | — | WO | claimed |
| US-20030113882-A1 | Methods for the preparation of beta-amino acids | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2003-06-19 | — | — | US | claimed |
| EP-0519971-B1 | NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS WHICH CAN BE FORMED FROM 1,3,4,6,7,8-HEXAHYDRO-2H-PYRIMIDO-(1,2-a)-PYRIMIDINE | INST SOZIAL MED FORSCHUNG SA (CH) | 1997-01-15 | — | — | EP | claimed |
| EP-0519971-A1 | NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS WHICH CAN BE FORMED FROM 1,3,4,6,7,8-HEXAHYDRO-2H-PYRIMIDO-(1,2-a)-PYRIMIDINE. | EEC PHARMA SA (FR) | 1992-12-30 | — | — | EP | claimed |
| WO-1991013886-A1 | NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS WHICH CAN BE FORMED FROM 1,3,4,6,7,8-HEXAHYDRO-2H-PYRIMIDO-(1,2-a)-PYRIMIDINE | EEC-PHARMA S.A. (FR) | 1991-09-19 | — | — | WO | claimed |